Advertisement
U.S. markets closed

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
36.89-2.07 (-5.31%)
At close: 04:00PM EST
36.90 +0.01 (+0.03%)
After hours: 07:40PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close38.96
Open39.20
Bid36.76 x 100
Ask37.00 x 100
Day's Range36.76 - 39.20
52 Week Range23.00 - 60.90
Volume2,073,267
Avg. Volume716,812
Market Cap2.161B
Beta (5Y Monthly)1.78
PE Ratio (TTM)N/A
EPS (TTM)-3.82
Earnings DateNov 18, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est50.39
  • Business Wire

    Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

    SOUTH SAN FRANCISCO, November 14, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3, 2024 at 10:00 a.m. Eastern Time in Coral Gables, Florida.

  • Business Wire

    Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., November 07, 2024--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 147,800 equity awards, consisting of 110,300 restricted stock units ("RSUs") to 43 recently hired individuals and an individually negotiated award of up to 37,50